{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T17:08:02Z","timestamp":1747156082095,"version":"3.40.5"},"reference-count":53,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Flemish Agency for Innovation by Science & Technology","award":["140045"],"award-info":[{"award-number":["140045"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.bcp.2015.06.003","type":"journal-article","created":{"date-parts":[[2015,6,12]],"date-time":"2015-06-12T09:37:54Z","timestamp":1434101874000},"page":"190-201","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Understanding the molecular mechanism of host-based statin resistance in hepatitis C virus replicon containing cells"],"prefix":"10.1016","volume":"96","author":[{"given":"Leen","family":"Delang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Els","family":"Scheers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mareike","family":"Grabner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ben","family":"Verpaalen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicky","family":"Helsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Els","family":"Vanstreels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dirk","family":"Daelemans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Verfaillie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0033-7514","authenticated-orcid":false,"given":"Johan","family":"Neyts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2015.06.003_bib0270","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1053\/j.gastro.2014.03.003","article-title":"New hepatitis C therapies: the toolbox, strategies, and challenges","volume":"146","author":"Pawlotsky","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bcp.2015.06.003_bib0275","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1254\/jphs.13R06CP","article-title":"Mechanism of statin-induced rhabdomyolysis","volume":"123","author":"Sakamoto","year":"2013","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.bcp.2015.06.003_bib0280","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/S0140-6736(04)15739-5","article-title":"Selenoprotein synthesis and side-effects of statins","volume":"363","author":"Moosmann","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.bcp.2015.06.003_bib0285","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1084\/jem.20040061","article-title":"Statins inhibit HIV-1 infection by down-regulating Rho activity","volume":"200","author":"Del Real","year":"2004","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bcp.2015.06.003_bib0290","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.micinf.2008.01.009","article-title":"Statin-induced inhibition of HIV-1 release from latently infected U1 cells reveals a critical role for protein prenylation in HIV-1 replication","volume":"10","author":"Amet","year":"2008","journal-title":"Microbes Infect."},{"key":"10.1016\/j.bcp.2015.06.003_bib0295","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/JVI.78.21.12062-12065.2004","article-title":"Statin compounds reduce human immunodeficiency virus type 1 replication by preventing the interaction between virion-associated host intercellular adhesion molecule 1 and its natural cell statin compounds reduce human immunodeficiency virus type 1 replica","volume":"78","author":"Gigu\u00e8re","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.bcp.2015.06.003_bib0300","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.bbrc.2006.06.107","article-title":"Role of simvastatin and methyl-\u03b2-cyclodextin on inhibition of poliovirus infection","volume":"347","author":"Liu","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bcp.2015.06.003_bib0305","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1161\/01.CIR.0000109485.79183.81","article-title":"Hydroxymethyl-glutaryl coenzyme A reductase inhibition limits cytomegalovirus infection in human endothelial cells","volume":"109","author":"Potena","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.bcp.2015.06.003_bib0310","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1159\/000321892","article-title":"Statins reduce dengue virus production via decreased virion assembly","volume":"54","author":"Mart\u00ednez-Gutierrez","year":"2011","journal-title":"Intervirology"},{"key":"10.1016\/j.bcp.2015.06.003_bib0315","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1128\/AAC.45.4.1231-1237.2001","article-title":"Antiviral activity of lovastatin against respiratory syncytial virus in vivo and in vitro","volume":"45","author":"Gower","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bcp.2015.06.003_bib0320","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.antiviral.2013.06.018","article-title":"Treating influenza with statins and other immunomodulatory agents","volume":"99","author":"Fedson","year":"2013","journal-title":"Antiviral Res."},{"key":"10.1016\/j.bcp.2015.06.003_bib0325","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/hep.21232","article-title":"Different anti-HCV profiles of statins and their potential for combination therapy with interferon","volume":"44","author":"Ikeda","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.bcp.2015.06.003_bib0330","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/hep.22916","article-title":"Statins potentiate the in vitro anti-hepatitis C virus activity of selective hepatitis C virus inhibitors and delay or prevent resistance development","volume":"50","author":"Delang","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.bcp.2015.06.003_bib0335","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1086\/525287","article-title":"Targeting lipid metabolism in the treatment of hepatitis C virus infection","volume":"197","author":"Amemiya","year":"2008","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.bcp.2015.06.003_bib0340","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1073\/pnas.0409834102","article-title":"Hepatitis C virus RNA replication is regulated by host geranylgeranylation and fatty acids","volume":"102","author":"Kapadia","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bcp.2015.06.003_bib0345","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.molcel.2005.04.004","article-title":"Identification of FBL2 as a geranylgeranylated cellular protein required for hepatitis C virus RNA replication","volume":"18","author":"Wang","year":"2005","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bcp.2015.06.003_bib0350","first-page":"8","article-title":"Fluvastatin interferes with hepatitis C virus replication via microtubule bundling and a doublecortin-like kinase-mediated mechanism","author":"Ali","year":"2013","journal-title":"PLOS ONE"},{"key":"10.1016\/j.bcp.2015.06.003_bib0355","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.antiviral.2013.04.009","article-title":"Statin therapy improves response to interferon alfa and ribavirin in chronic hepatitis C: a systematic review and meta-analysis","volume":"98","author":"Zhu","year":"2013","journal-title":"Antiviral Res."},{"key":"10.1016\/j.bcp.2015.06.003_bib0360","first-page":"5","article-title":"Deb025 (Alisporivir) inhibits hepatitis c virus replication by preventing a cyclophilin a induced Cis-trans isomerisation in domain ii of NS5A","author":"Coelmont","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bcp.2015.06.003_bib0365","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1128\/AAC.05762-11","article-title":"ENT1, a ribavirin transporter, plays a pivotal role in antiviral efficacy of ribavirin in a hepatitis C virus replication cell system","volume":"56","author":"Iikura","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bcp.2015.06.003_bib0370","doi-asserted-by":"crossref","first-page":"S325","DOI":"10.2337\/dcS13-2038","article-title":"Intolerance to statins: mechanisms and management","volume":"36","author":"Bitzur","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.bcp.2015.06.003_bib0375","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.ahj.2013.06.004","article-title":"Treatment strategies in patients with statin intolerance: the Cleveland Clinic experience","volume":"166","author":"Mampuya","year":"2013","journal-title":"Am. Heart J."},{"key":"10.1016\/j.bcp.2015.06.003_bib0380","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1126\/science.285.5424.110","article-title":"Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line","volume":"285","author":"Lohmann","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.bcp.2015.06.003_bib0385","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1128\/JVI.79.1.380-392.2005","article-title":"Kissing\u2013loop interaction in the 3\u2032 end of the hepatitis C virus genome essential for RNA replication","volume":"79","author":"Friebe","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.bcp.2015.06.003_bib0390","doi-asserted-by":"crossref","first-page":"5456","DOI":"10.1128\/AAC.03052-14","article-title":"Genotypic and phenotypic analyses of hepatitis C virus variants observed in clinical studies of VX-222, a nonnucleoside NS5B polymerase inhibitor","volume":"58","author":"Jiang","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bcp.2015.06.003_bib0395","doi-asserted-by":"crossref","first-page":"3641","DOI":"10.1128\/AAC.00556-10","article-title":"Resistance analysis of the hepatitis C virus NS5A inhibitor BMS-790052 in an in vitro replicon system","volume":"54","author":"Fridell","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bcp.2015.06.003_bib0400","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/978-1-62703-484-5_8","article-title":"Selecting and characterizing drug-resistant hepatitis C virus replicon","volume":"1030","author":"Vliegen","year":"2013","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.bcp.2015.06.003_bib0405","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1152\/physrev.00037.2005","article-title":"Human multidrug resistance ABCB and ABCG transporters: participation in a chemoimmunity defense system","volume":"86","author":"Sarkadi","year":"2006","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bcp.2015.06.003_bib0410","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2174\/1568011043482197","article-title":"Reversing agents for ATP-binding cassette (ABC) transporters: application in modulating multidrug resistance (MDR)","volume":"4","author":"Lee","year":"2004","journal-title":"Curr. Med. Chem. Anticancer Agents"},{"key":"10.1016\/j.bcp.2015.06.003_bib0415","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1001\/jama.291.23.2821","article-title":"Pharmacogenetic study of statin therapy and cholesterol reduction","volume":"291","author":"Chasman","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.bcp.2015.06.003_bib0420","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1161\/CIRCULATIONAHA.107.708388","article-title":"Variation in the 3-hydroxyl-3-methylglutaryl coenzyme A reductase gene is associated with racial differences in low-density lipoprotein cholesterol response to simvastatin treatment","volume":"117","author":"Krauss","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.bcp.2015.06.003_bib0425","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0163-7827(01)00010-8","article-title":"Sterol regulatory element-binding proteins (SREBPs): transcriptional regulators of lipid synthetic genes","volume":"40","author":"Shimano","year":"2001","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.bcp.2015.06.003_bib0430","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1517\/17425251003713519","article-title":"Efflux and uptake transporters as determinants of statin response","volume":"6","author":"Rodrigues","year":"2010","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.bcp.2015.06.003_bib0435","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1124\/dmd.104.002477","article-title":"Differential interaction of 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors with ABCB1, ABCC2, and OATP1B1","volume":"33","author":"Chen","year":"2005","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bcp.2015.06.003_bib0440","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1124\/dmd.111.038075","article-title":"Use of transporter knockdown caco-2 cells to investigate the in vitro efflux of statin drugs","volume":"39","author":"Li","year":"2011","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bcp.2015.06.003_bib0445","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1159\/000065614","article-title":"Gene therapy for sarcoma","volume":"172","author":"Fruehauf","year":"2002","journal-title":"Cells Tissues Organs"},{"key":"10.1016\/j.bcp.2015.06.003_bib0450","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1073\/pnas.79.4.1185","article-title":"Appearance of crystalloid endoplasmic reticulum in compactin-resistant Chinese hamster cells with a 500-fold increase in 3-hydroxy-3-methylglutaryl-coenzyme A reductase","volume":"79","author":"Chin","year":"1982","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bcp.2015.06.003_bib0455","doi-asserted-by":"crossref","first-page":"6762","DOI":"10.1016\/S0021-9258(19)69057-5","article-title":"Isolation and characterization of cells resistant to ML236B (Compactin) with increased levels of 3-hydroxy-3-methylglutaryl coenzyme A reductase","volume":"256","author":"Ryan","year":"1981","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2015.06.003_bib0460","doi-asserted-by":"crossref","first-page":"29341","DOI":"10.1074\/jbc.274.41.29341","article-title":"Impaired regulation of 3-hydroxy-3-methylglutaryl-coenzyme a reductase degradation in lovastatin-resistant cells","volume":"274","author":"Ravid","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2015.06.003_bib0465","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/BF02090780","article-title":"Lack of correlation between 3-hydroxy-3-methylglutaryl coenzyme A reductase activity and lovastatin resistance in nerve growth factor treated PC-12 cells","volume":"14","author":"Marom","year":"1994","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.bcp.2015.06.003_bib0470","first-page":"1","article-title":"Inflammatory stress reduces the effectiveness of statins in the kidney by disrupting HMGCoA reductase feedback regulation","author":"Chen","year":"2014","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.bcp.2015.06.003_bib0475","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1161\/CIRCGENETICS.108.795013","article-title":"Pharmacogenetic predictors of statin-mediated low-density lipoprotein cholesterol reduction and dose response","volume":"1","author":"Voora","year":"2008","journal-title":"Circ. Cardiovasc. Genet."},{"key":"10.1016\/j.bcp.2015.06.003_bib0480","doi-asserted-by":"crossref","first-page":"5981","DOI":"10.1073\/pnas.1218778110","article-title":"The mitochondrial unfolded protein response activator ATFS-1 protects cells from inhibition of the mevalonate pathway","volume":"110","author":"Rauthan","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bcp.2015.06.003_bib0485","doi-asserted-by":"crossref","first-page":"375","DOI":"10.2133\/dmpk.19.375","article-title":"Effect of genetic polymorphism of OATP-C (SLCO1B1) on lipid-lowering response to HMG-CoA reductase inhibitors","volume":"19","author":"Tachibana-Iimori","year":"2004","journal-title":"Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.bcp.2015.06.003_bib0490","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0014-5793(85)80712-2","article-title":"A somatic cell mutant with a kinetically altered 3-hydroxy-3-methylglutaryl coenzyme A reductase","volume":"186","author":"Sinensky","year":"1985","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bcp.2015.06.003_bib0495","doi-asserted-by":"crossref","first-page":"7273","DOI":"10.1128\/JVI.00629-11","article-title":"Host-based ribavirin resistance influences hepatitis C virus replication and treatment response","volume":"85","author":"Ibarra","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.bcp.2015.06.003_bib0500","doi-asserted-by":"crossref","first-page":"4538","DOI":"10.1128\/JVI.02280-08","article-title":"Reduced ribavirin antiviral efficacy via nucleoside transporter-mediated drug resistance","volume":"83","author":"Ibarra","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.bcp.2015.06.003_bib0505","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/S0959-8049(05)80216-3","article-title":"Clinical application of a rapid, functional assay for multidrug resistance based on accumulation of the fluorescent dye, fluo-3","volume":"29A","author":"Wall","year":"1993","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.bcp.2015.06.003_bib0510","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1042\/BJ20060632","article-title":"Modulation of drug-stimulated ATPase activity of human MDR1\/P-glycoprotein by cholesterol","volume":"401","author":"Kimura","year":"2007","journal-title":"Biochem. J."},{"key":"10.1016\/j.bcp.2015.06.003_bib0515","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1006\/bbrc.1999.1996","article-title":"Overexpression of MDR1 in an intestinal cell line results in increased cholesterol uptake from micelles","volume":"267","author":"Tessner","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bcp.2015.06.003_bib0520","doi-asserted-by":"crossref","first-page":"3203","DOI":"10.1021\/mp4002415","article-title":"Evaluation of the contribution of the ATP binding cassette transporter, P-glycoprotein, to in vivo cholesterol homeostasis","volume":"10","author":"Lee","year":"2013","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.bcp.2015.06.003_bib0525","doi-asserted-by":"crossref","first-page":"4086","DOI":"10.1182\/blood.V93.12.4086","article-title":"Altered multidrug resistance phenotype caused by anthracycline analogues and cytosine arabinoside in myeloid leukemia","volume":"93","author":"Hu","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2015.06.003_bib0530","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1093\/jnci\/85.8.632","article-title":"Induction of multidrug resistance in human cells by transient exposure to different chemotherapeutic drugs","volume":"85","author":"Chaudhary","year":"1993","journal-title":"J. Natl. Cancer Inst."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295215003196?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295215003196?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,12]],"date-time":"2022-05-12T21:06:59Z","timestamp":1652389619000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295215003196"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":53,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S0006295215003196"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2015.06.003","relation":{},"ISSN":["0006-2952"],"issn-type":[{"type":"print","value":"0006-2952"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Understanding the molecular mechanism of host-based statin resistance in hepatitis C virus replicon containing cells","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2015.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}